ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 150289 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 150289; 2) Community: the network communities that were significantly associated with the response to NSC 150289; 3) Molecule: the relationships between components within communities and NSC 150289; 4) MDR: the compounds that were significantly associated with the NSC 150289.

NSC Compound Enrichment Correlation
NSC 700455 Quinoline-3,3,4,4-tetracarbonitrile, 2-(4-bromophenyl)-1,2,3,4,5,6,7,8-octahydro- 0.00396220821750022 0.51474549
NSC 701383 Null 0.00396220821750022 0.61720366
NSC 703544 Null 0.00396220821750022 0.45512245
NSC 71669 Null 0.00396220821750022 0.29268971
NSC 716951 Null 0.00396220821750022 0.2546234
NSC 720447 Null 0.00396220821750022 -0.43041393
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.00396220821750022 0.36608174
NSC 726267 Null 0.00396220821750022 -0.017655013
NSC 740 Methotrexate 0.00396220821750022 0.4474282
NSC 740024 4-(2-Benzylthio-4-chloro-5-methylbenzenesulfonyl)-5,7-dimeth yl-2,4-dihydro-[1,2,4]triazepin-3-ylideneamine 0.00396220821750022 0.39472814
Total:162  Current:31    [First] [Prev] [Next] [Last]